Organovo (ONVO) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONVO vs. ORGS, TXMD, BGXX, AFMD, NERV, RLYB, RLMD, PHXM, IXHL, and GOVXShould you be buying Organovo stock or one of its competitors? The main competitors of Organovo include Orgenesis (ORGS), TherapeuticsMD (TXMD), Bright Green (BGXX), Affimed (AFMD), Minerva Neurosciences (NERV), Rallybio (RLYB), Relmada Therapeutics (RLMD), PHAXIAM Therapeutics (PHXM), Incannex Healthcare (IXHL), and GeoVax Labs (GOVX). These companies are all part of the "pharmaceutical products" industry. Organovo vs. Orgenesis TherapeuticsMD Bright Green Affimed Minerva Neurosciences Rallybio Relmada Therapeutics PHAXIAM Therapeutics Incannex Healthcare GeoVax Labs Orgenesis (NASDAQ:ORGS) and Organovo (NASDAQ:ONVO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation. Which has more volatility and risk, ORGS or ONVO? Orgenesis has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Organovo has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Which has stronger earnings & valuation, ORGS or ONVO? Organovo has lower revenue, but higher earnings than Orgenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrgenesis$662K16.04-$55.36MN/AN/AOrganovo$122K0.00-$14.67M-$10.20N/A Do insiders and institutionals have more ownership in ORGS or ONVO? 22.6% of Orgenesis shares are held by institutional investors. Comparatively, 8.2% of Organovo shares are held by institutional investors. 5.7% of Orgenesis shares are held by company insiders. Comparatively, 3.7% of Organovo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer ORGS or ONVO? Organovo received 195 more outperform votes than Orgenesis when rated by MarketBeat users. However, 100.00% of users gave Orgenesis an outperform vote while only 45.69% of users gave Organovo an outperform vote. CompanyUnderperformOutperformOrgenesisOutperform Votes1100.00% Underperform VotesNo VotesOrganovoOutperform Votes19645.69% Underperform Votes23354.31% Is ORGS or ONVO more profitable? Orgenesis has a net margin of -3,827.81% compared to Organovo's net margin of -10,151.64%. Orgenesis' return on equity of 0.00% beat Organovo's return on equity.Company Net Margins Return on Equity Return on Assets Orgenesis-3,827.81% N/A -130.18% Organovo -10,151.64%-346.26%-187.53% Does the media favor ORGS or ONVO? In the previous week, Organovo had 1 more articles in the media than Orgenesis. MarketBeat recorded 2 mentions for Organovo and 1 mentions for Orgenesis. Organovo's average media sentiment score of 0.63 beat Orgenesis' score of 0.00 indicating that Organovo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orgenesis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Organovo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOrgenesis beats Organovo on 7 of the 12 factors compared between the two stocks. Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONVO vs. The Competition Export to ExcelMetricOrganovoBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.47M$2.95B$5.53B$7.93BDividend YieldN/A1.89%5.11%4.22%P/E Ratio-2.4030.0722.5118.54Price / SalesN/A494.82397.62103.30Price / CashN/A168.6838.1834.62Price / BookN/A3.176.734.25Net Income-$14.67M-$72.35M$3.22B$248.18M Organovo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONVOOrganovo0.6009 of 5 starsN/AN/AN/A$3.47M$122,000.00-2.4020Gap DownORGSOrgenesisN/A$2.48+13.2%N/AN/A$11.90M$662,000.000.00150Gap DownTXMDTherapeuticsMD1.766 of 5 stars$1.00-1.4%N/A-26.1%$11.53M$1.76M0.00420Upcoming EarningsAnalyst ForecastBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002Gap DownAFMDAffimed3.4915 of 5 stars$0.70-4.0%$13.50+1,818.2%-79.4%$11.33M$877,000.000.00200NERVMinerva Neurosciences3.7898 of 5 stars$1.66+3.8%$5.00+201.2%-27.7%$11.19MN/A-3.779RLYBRallybio2.3204 of 5 stars$0.27+6.0%$10.00+3,672.2%-84.1%$11.03M$636,000.00-0.1740Upcoming EarningsRLMDRelmada Therapeutics4.3625 of 5 stars$0.32+11.5%$4.25+1,215.8%-90.5%$10.72MN/A-0.1110Upcoming EarningsPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049IXHLIncannex Healthcare0.6333 of 5 stars$0.59-1.7%N/A-95.0%$10.54M$98,000.00-0.423GOVXGeoVax Labs2.9607 of 5 stars$0.76-8.4%$12.90+1,597.1%-33.2%$10.52M$3.95M-0.1310Earnings ReportAnalyst ForecastNews CoveragePositive News Related Companies and Tools Related Companies Orgenesis Competitors TherapeuticsMD Competitors Bright Green Competitors Affimed Competitors Minerva Neurosciences Competitors Rallybio Competitors Relmada Therapeutics Competitors PHAXIAM Therapeutics Competitors Incannex Healthcare Competitors GeoVax Labs Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONVO) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organovo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organovo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONVO Stock Free ONVO Stock Alerts